1. From Rutgers Biomedical and Health Sciences, Newark, NJ (B.L.S.); Hasselt University, Hasselt, and the International Drug Development Institute, Louvain-la-Neuve — both in Belgium (M.B.); the United Kingdom Clinical Research Collaboration Board, London (J.H.); and the Center of Genomics and Policy, McGill University, Montreal (B.M.K.).